High resolution allele genotyping and haplotype frequencies for NGS based HLA 11 loci of 5266 Hong Kong Chinese bone marrow donors

Hum Immunol. 2020 Oct-Nov;81(10-11):577-579. doi: 10.1016/j.humimm.2020.08.005. Epub 2020 Sep 4.

Abstract

Next-generation sequencing (NGS) at the HLA-A, -B, -C, -DRB1, -DRB3/4/5, -DQA1, -DQB1, -DPA1, and -DPB1 loci was performed on 5,266 southern Chinese unrelated donors of the Hong Kong Bone Marrow Donor Registry. High-resolution HLA genotypes defined by full sequencing of class I loci and extended coverage of class II loci were attained to determine allele frequencies and estimate haplotype frequencies. This study provides allele and haplotype frequencies on 11 loci estimated for the first time in the Hong Kong Chinese population. These results describe extended haplotypes including the less frequently typed HLA-DPA1, -DPB1 and -DQA1 loci and distinctive haplotype associations. The present data are timely in that they allow the permissible matching in HLA-DPB1 for Chinese patients awaiting haematopoietic stem cell transplantation upon applying the latest requirement of NMDP matching guidelines. Overall, these results provide a useful reference source for population genetics studies, HLA-disease association studies and for improving donor recruitment and selection strategies of bone marrow registries. The allele and haplotype data are available in the Allele Frequencies Net Database under the population name ''Hong Kong Chinese HKBMDR, HLA 11 loci'' and the identifier (AFND3724) [1].

Keywords: Chinese; Gene frequency; HLA; Haplotype frequency; Hong Kong; Registry.

MeSH terms

  • Alleles*
  • Asian People / genetics
  • Bone Marrow / immunology*
  • Bone Marrow Transplantation
  • Gene Frequency*
  • Genetic Loci*
  • Genotyping Techniques / methods
  • HLA Antigens / genetics*
  • Haplotypes*
  • High-Throughput Nucleotide Sequencing / methods
  • Histocompatibility Antigens Class I / genetics
  • Histocompatibility Antigens Class II / genetics
  • Histocompatibility Testing / methods
  • Hong Kong
  • Humans
  • Registries*
  • Unrelated Donors*

Substances

  • HLA Antigens
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II